Evidence map›Paper›PMID 19053762›Full record

ArticleJournal of medicinal chemistry2008

Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.

Amol Gupte, Helena I Boshoff, Daniel J Wilson, João Neres, Nicholas P Labello, Ravindranadh V Somu, Chengguo Xing, Clifton E Barry, Courtney C Aldrich

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Rational inhibitor design for Pseudomonas aeruginosa salicylate adenylation enzyme PchD.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2022
    Article
  5. Article
  6. 1,2,3-Triazoles as leaving groups: SBeilstein journal of organic chemistry · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bisubstrate Inhibitors of Biotin Protein Ligase inACS medicinal chemistry letters · 2013
    Article
  18. Article
  19. Article
  20. Targeting iron assimilation to develop new antibacterials.Expert opinion on drug discovery · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Amol GupteCenter for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Helena I Boshoff
Daniel J Wilson
João Neres
Nicholas P Labello
Ravindranadh V Somu
Chengguo Xing
Clifton E Barry
Courtney C Aldrich
National Institute of Allergy and Infectious Diseases · USUniversity of Minnesota · US

Funding

Development Of New Chemotherapeutics For TuberculosisZIAAI000693 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2025
$20.1M
PATHOGENIC MECHANISMS OF MYCOBACTERIUM TUBERCULOSISZ01AI000693 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI BARRY, CLIFTON · 1993 to 2008
$8.1M
Design of Antituberculosis Agents that Target Siderophore BiosynthesisR01AI070219 · NIAID · UNIVERSITY OF MINNESOTA · PI ALDRICH, COURTNEY C · 2006 to 2013
$2.2M
Intramural NIH HHS Z01 AI000693NIAID NIH HHS R01 AI070219NIAID NIH HHS R01AI070219
6 · The paper itself

Abstract

The synthesis, biochemical, and biological evaluation of a systematic series of 2-triazole derivatives of 5'-O-[N-(salicyl)sulfamoyl]adenosine (Sal-AMS) are described as inhibitors of aryl acid adenylating enzymes (AAAE) involved in siderophore biosynthesis by Mycobacterium tuberculosis. Structure-activity relationships revealed a remarkable ability to tolerate a wide range of substituents at the 4-position of the triazole moiety, and a majority of the compounds possessed subnanomolar apparent inhibition constants. However, the in vitro potency did not always translate into whole cell biological activity against M. tuberculosis, suggesting that intrinsic resistance plays an important role in the observed activities. Additionally, the well-known valence tautomerism between 2-azidopurines and their fused tetrazole counterparts led to an unexpected facile acylation of the purine N-6 amino group.

Indexed as

AdenosineAnimalsAntitubercular AgentsCell Line, TumorCell ProliferationChlorocebus aethiopsComputer SimulationCrystallography, X-RayDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansMicrobial Sensitivity TestsModels, ChemicalModels, MolecularMolecular StructureMycobacterium tuberculosis5'-O-(N-(salicyl)sulfamoyl)adenosineAdenosineAntitubercular AgentsSiderophoresTriazoles

Identifiers

PMID19053762
PMCPMC2750848
OpenAlexW2059761248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.